Onconetix, Inc. Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent
Onconetix, Inc. (ONCO) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent of -$345.32 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent · last filed 2026-08-13
- Onconetix, Inc. other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for the quarter ending 2025-06-30 was -$345.32K.
- Onconetix, Inc. other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for the quarter ending 2025-03-31 was $30.78K.
- Onconetix, Inc. other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2023 was $7.28K.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent 12 month |
|---|---|---|---|
| 2025-06-30 | -$345.32K 10-Q · filed 2026-08-13 | -$314.54K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $30.78K 10-Q · filed 2026-05-13 | ||
| 2023-12-31 | $7.28K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |